Our Company
Our Science
Our Products & Services

Our News Hub
Your Career
Contact
EN

$0.00

✕

About

Home
About

August 10, 2023

Published by gyuser on August 10, 2023

Categories

2011

Pharmazac expands to the U.K. market.

Do you like it?0

Follow us

Headquarters, Pharmaceutical Manufacturing Site & R&D Lab

1, A. Zaroliagki & 6, D. Lamprou Str.
GR-19001 Keratea
Greece
Center: +30 210 3418889-97
e-mail: pharmazac@pharmazac.com

Radiopharmaceutical Manufacturing Site

Lamia Industrial Zone, 3 & 3A Str.
OT 4B, GR-35100 Lamia
Greece
Center: +30 210 3418889-95

Report an Adverse Event / Pharmacovigilance

For any adverse event report
please contact Errietta Economou,
Head of Vigilance
Mobile: +30 6946463306 (24/7)
e-mail: eeconomou@vigi-care.eu

Corporate Statements and Publications

Media Material
Corporate Presentation
CMO/CDMO Services

© 2026 | All Rights Reserved

Web Design & Development by Generation Y

$0.00

No translations available for this page

Login

Username or email *

Password *

Remember me

Lost your password?